Article & News

At least 15 drug­makers are in the fray to tap the estim­ated ₹5,000 crore oppor­tun­ity emer­ging from sema­glu­tide’s pat­ent expiry, but the road to for­eign

The upward trajectory of weight-loss and diabetes drugs continues, as Eli Lilly’s Mounjaro clocks sales of over ₹100 crore in December 2025 – making it

More than 60% of India’s small and medium pharmaceutical enterprises (SMEs) face a potential shutdown by December 31, 2025, following non-compliance with revised Good Manufacturing

A leading thinker in the field of aging research, Dr. David Sinclair, shares insights on the rapid pace of advancements in aging research and predicts

When the world was gripped by uncertainty during the COVID-19 pandemic, vaccines became more than a medical solution. They turned into a measure of global

Indian drug­makers such as Dr. Reddy’s and Sun Phar­ma­ceut­ical Indus­tries are already play­ing catch-up with Bangladesh, even as they pre­pare to enter the global mar­ket

Mumbai, Dec 19 (UNI) A special NDPS court here has sentenced two pharmacists to 20 years of Rigorous Imprisonment and levied a fine of Rs

India has set a minimum import price for essential drug ingredients. This move aims to protect domestic manufacturers from aggressive pricing by Chinese companies. The

Fortis Healthcare amongst India’s leading healthcare delivery companies, announced signing of definitive agreements for the acquisition of the 125-bedded People Tree Hospital in Yeshwanthpur, Bengaluru

Indian Pharmaceutical Alliance (IP Alliance) is investing $15 million to set up a dedicated quality institute in Ahmedabad. This will be focused on quality parametres